Loading…

BioCheck, Inc. announced the acquisition of DRG International, a manufacturer of clinical diagnostic and research ELISAs, on August 18, 2021. The deal expands BioCheck's IVD development and sales channels.
“the DRG:HYBRiD-XL® and BioCheck's new automated chemiluminescent platform (ACL-Platform) will enable us to accelerate the availability of optimized, reliable and accurate advanced clinical and research diagnostic tests”biospace.com
Summarized from public sources; check the original articles before acting on it.